This enables insights into the impact of cancer‐related DNMT mutations on in vivo catalysis, enables local and tuneable methylation via DNMT‐TAL‐effector fusions, and provides insights into methylation‐triggered transcriptome dynamics. The gene discussed is DNMT1; the disease is cancer.